{"organizations": [], "uuid": "057b98e24fd10d73e938603e767ba08e8b88c236", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-htg-molecular-diagnostics-secures/brief-htg-molecular-diagnostics-secures-debt-facility-with-midcap-financial-idUSFWN1R90D3", "country": "US", "domain_rank": 408, "title": "BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-27T15:07:00.000+03:00", "replies_count": 0, "uuid": "057b98e24fd10d73e938603e767ba08e8b88c236"}, "author": "", "url": "https://www.reuters.com/article/brief-htg-molecular-diagnostics-secures/brief-htg-molecular-diagnostics-secures-debt-facility-with-midcap-financial-idUSFWN1R90D3", "ord_in_thread": 0, "title": "BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-htg molecular diagnostics", "sentiment": "negative"}, {"name": "htg molecular diagnostics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 08 PM / Updated 24 minutes ago BRIEF-Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial Reuters Staff March 27 (Reuters) - Htg Molecular Diagnostics Inc: * HTG MOLECULAR DIAGNOSTICS SECURES DEBT FACILITY WITH MIDCAP FINANCIAL * HTG MOLECULAR DIAGNOSTICS INC - ‍ENTERED INTO A SENIOR DEBT FACILITY WITH MIDCAP FINANCIAL TO REPLACE ITS EXISTING SENIOR CREDIT FACILITY * HTG MOLECULAR DIAGNOSTICS INC - ‍DURATION OF TERM LOAN IS FIVE YEARS, WITH INTEREST ONLY PAYMENTS FOR FIRST TWO YEARS​ * HTG MOLECULAR DIAGNOSTICS - ‍SENIOR FACILITY ALSO INCLUDES AN INITIAL $2.0 MILLION REVOLVING LINE OF CREDIT, SECURED BY ACCOUNTS RECEIVABLE AND INVENTORY​ * HTG MOLECULAR DIAGNOSTICS INC - ‍REVOLVING LINE OF CREDIT IS EXPANDABLE TO UP TO $10.0 MILLION UNDER CERTAIN CONDITIONS OVER A FIVE-YEAR PERIOD​ * HTG MOLECULAR DIAGNOSTICS-UP TO $30.0 MILLION CREDIT FACILITY CONSISTS OF $7.0 MILLION TERM LOAN WITH ABILITY TO ACCESS ANOTHER $13.0 MILLION ADDITIONAL TRANCHE Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-03-27T15:07:00.000+03:00", "crawled": "2018-03-27T15:36:11.083+03:00", "highlightTitle": ""}